๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: Morphometric analysis of repeated biopsies

โœ Scribed by M Kage; K Shimamatu; E Nakashima; M Kojiro; O Inoue; M Yano


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
177 KB
Volume
25
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


atitis activity index scoring system 14 and others, [15][16][17] have To clarify the characteristics of fibrosis developed in been used in the assessment of the degree of fibrosis, howthe process from chronic hepatitis C to cirrhosis, a morever, these methods cannot completely avoid the observer's phometric analysis of liver biopsy samples was conbias. In the present study, we selected chronic hepatitis C ducted on 25 chronic hepatitis C patients and 20 chronic patients who developed cirrhosis and underwent multiple hepatitis B patients (controls). Hepatitis C patients were liver biopsy procedures; and conducted a quantitative analyfollowed up for 3 to 23 years. The mean number of liver sis using morphometry to determine chronological changes biopsies performed on these patients was 3.8. Each biof fibrosis in the course from chronic hepatitis to cirrhosis. opsy was evaluated for the degree of fibrosis by using

The result of the initial biopsy was also assessed as to two methods: a semiquantitative method with a staging whether it could be a predictive factor for the development scoring system, and morphometry using a computed imof cirrhosis from chronic hepatitis C. age analysis system. A significant correlation was observed between the Stage and the area of fibrosis (AF ร…

PATIENTS AND METHODS

the ratio of the area of fibrosis to that of the entire tissue specimen). The AF in cirrhosis was significantly higher

We examined 25 patients with chronic hepatitis C who were positive for hepatitis C virus antibodies by a second generation assay, in hepatitis C patients than in hepatitis B patients. The negative to hepatitis B surface antigen, and eventually developed ratio of AF in the last biopsy sample to AF in the initial cirrhosis during clinical observation. They were selected from ap-

biopsy sample was significantly higher in hepatitis C

proximately 1,000 patients with chronic liver diseases seen at Napatients than in hepatitis B patients. Evolution from tional Nagasaki Chuo Hospital, Ohmura, Japan during the period chronic hepatitis C to cirrhosis occurred more frefrom 1967 to 1994. They were willing to undergo biopsy procedures quently in patients aged ยข50 years, and this time period and to be followed up at a regular interval because of fluctuations was 1.8 times shorter than that in patients aged รต50 in their serum alanine aminotransferase levels. The initial biopsy years. AF in the initial biopsy related significantly to the was usually undertaken within 6 months after the disease onset. period of evolution from chronic hepatitis C to cirrhosis. Patients, whose initial biopsy showed cirrhosis, were excluded from the study. Ten of the 25 patients had received blood transfusions, AF in the initial biopsy might be a predictive factor for and three of them were followed up after having developed acute prognosis. (HEPATOLOGY 1997;25:1028-1031.) hepatitis after transfusion. Development of cirrhosis was diagnosed based on biopsy findings and clinical findings including those of laparoscopy. Liver biopsy was performed repeatedly in 11 patients even Abbreviation: AF, area of fibrosis.


๐Ÿ“œ SIMILAR VOLUMES


Evolution of hepatic steatosis in patien
โœ Anna S. Lok; James E. Everhart; Raymond T. Chung; Hae-Young Kim; Gregory T. Ever ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 404 KB ๐Ÿ‘ 2 views

Hepatic steatosis is a common histologic feature in patients with chronic hepatitis C (CHC) but there are no large longitudinal studies describing the progression of steatosis in CHC. We examined changes in steatosis on serial biopsies among CHC patients participating in the Hepatitis C Antiviral Lo

Clinical significance of hepatic HCV RNA
โœ Larghi, Alberto; Tagger, Alessandro; Crosignani, Andrea; Ribero, Maria Lisa; Bru ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-โฃ (IFN-โฃ) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RN

Effect of interferon therapy on hepatoce
โœ Kenji Ikeda; Satoshi Saitoh; Yasuji Arase; Kazuaki Chayama; Yoshiyuki Suzuki; Ma ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB

The activity of interferon (IFN) is not elucidated from the viewpoint of cancer prevention in chronic hepatitis C patients en masse. The hepatocellular carcinogenesis rate was analyzed statistically in 1,643 patients with chronic hepatitis C: 1,191 patients with IFN therapy and 452 without IFN thera